EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of type 2 diabetes treatment status with in vivo biomarkers of Alzheimer's disease

Muge Akinci iD, Froogh Aziz, Diana Guzman, Lina Cheung, Jian X Kong, Stephanie Silver, Joseph Eimicke, Jeanne A Teresi, Adam M Brickman, Patrick Lao, José A Luchsinger

Alzheimer's & Dementia · 2026-02 · 22 (2)

DOI: 10.1002/alz.71214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 24.02.2026. Verfasst von Muge Akinci und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Alzheimer Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: United States National Institutes of Health, NIA NIH HHS, Reid and Wethington.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The association of type 2 diabetes (T2D) treatment with Alzheimer's disease (AD) is unclear. We examined T2D treatment status in relation to amyloid beta (Aβ) burden and AD‐related downstream processes. METHODS This cross‐sectional study included 546 cognitively unimpaired adults (mean age = 64.2 ± 3.2 years, 65% women), classified into normal glucose tolerance (NGT; hemoglobin A1c [HbA1c] < 5.7%), prediabetes/untreated T2D (HbA1c ≥ 5.7%), and treated T2D groups. Multiple regression analyses assessed group differences in Aβ ( 18 F‐florbetaben) and tau ( 18 F‐MK‐6240) positron emission tomography burden, magnetic resonance imaging–based AD signature cortical thickness, white matter hyperintensity (WMH) volume, and memory performance. RESULTS Compared to the NGT group, prediabetes/untreated T2D had greater anterior/posterior cingulate and superior parietal cortex Aβ burden, whereas treated T2D had lower cortical thickness and greater WMHs, independent of demographics and apolipoprotein E ε4 status. No group differences were found in tau or memory outcomes. DISCUSSION Prediabetes/untreated T2D, but not treated T2D, was associated with early Aβ deposition. Diabetes medications may mitigate brain Aβ burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Alzheimer DiseaseHumansFemalePositron-Emission TomographyCross-Sectional StudiesMaleAgedMagnetic Resonance ImagingBiomarkersAmyloid beta-Peptidestau ProteinsMiddle AgedBrainPrediabetic StateGlycated HemoglobinWhite MatterAniline CompoundsStilbenes

Stichwörter der Autor:innen

Alzheimer's pathologyamyloid beta positron emission tomographycognitiondiabetes treatmentneurodegenerationprediabetestau positron emission tomographytype 2 diabeteswhite matter hyperintensity

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsGlycated HemoglobinAniline CompoundsStilbenes

Autor:innen und Institutionen

  • Department of Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA.
  • Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Morris Stroud III Center for Study of Quality of Life in Health and Aging, Columbia University, New York, New York, USA.
  • Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Gertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Department of Epidemiology, Joseph P. Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York, USA.

ORCID-Profile: Muge Akinci

Förderung

  • United States National Institutes of Health
  • NIA NIH HHS
  • Reid and Wethington
  • Manly and Brickman
  • Columbia Alzheimer's Disease Resource Centers for Minority Aging Research
  • Pepper Older Americans Independence Center
  • Morrison and Aldrich
  • Cornell Roybal Center-Translational Research Institute on Pain in Later Life

Zitieren

APA

Akinci, M., Aziz, F., Guzman, D., Cheung, L., Kong, J. X., Silver, S., Eimicke, J., Teresi, J. A., Brickman, A. M., Lao, P., & Luchsinger, J. A. (2026). Association of type 2 diabetes treatment status with in vivo biomarkers of Alzheimer's disease. Alzheimer's & Dementia, 22(2). https://doi.org/10.1002/alz.71214

Vancouver

Akinci M, Aziz F, Guzman D, Cheung L, Kong JX, Silver S, et al. Association of type 2 diabetes treatment status with in vivo biomarkers of Alzheimer's disease. Alzheimer's & Dementia. 2026;22(2). doi:10.1002/alz.71214

BibTeX
@article{Akinci2026,
  author = {Akinci, Muge and Aziz, Froogh and Guzman, Diana and Cheung, Lina and Kong, Jian X and Silver, Stephanie and Eimicke, Joseph and Teresi, Jeanne A and Brickman, Adam M and Lao, Patrick and Luchsinger, José A},
  title = {Association of type 2 diabetes treatment status with in vivo biomarkers of Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {2},
  doi = {10.1002/alz.71214}
}
Kostenlos starten →